UnknownNCT03015974

Registry of IgA Nephropathy in Chinese Children

Studying IgA Nephropathy

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Peking University First Hospital
Principal Investigator
Jie Ding, Prof.
Peking University First Hospital
Intervention
Corticosteroid(drug)
Enrollment
1200 enrolled
Eligibility
18 years · All sexes
Timeline
2016 – 2024

Study locations (1)

Collaborators

Nanjing PLA General Hospital · Beijing Children's Hospital · Central South University · The Children's Hospital of Zhejiang University School of Medicine · First Affiliated Hospital, Sun Yat-Sen University · Tongji Hospital · Hunan Children's Hospital · Shanghai Children's Hospital · Nanjing Children's Hospital · Children's Hospital of Chongqing Medical University · Shandong Provincial Hospital · Fuzhou General Hospital · Second Affiliated Hospital of Wenzhou Medical University · Children's Hospital of Hebei Province · Guangzhou Women and Children's Medical Center · Jiangxi Province Children's Hospital · Guangzhou First People's Hospital · Xian Children's Hospital · Capital Institute of Pediatrics, China · The First Hospital of Jilin University · Wuhan Women and Children's Medical Center · Tianjin Children's Hospital · Chengdu Women's and Children's Central Hospital · The First People's Hospital of Yunnan

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03015974 on ClinicalTrials.gov

Other trials for IgA Nephropathy

Additional recruiting or active studies for the same condition.

See all trials for IgA Nephropathy →

← Back to all trials